De-Escalation Protocol Of HPV Mediated Oropharyngeal Squamous Cell Carcinoma
Conditions: HPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Clinical Stage; Oropharynx Cancer Interventions: Procedure: Transoral robotic surgery; Drug: Cisplatin - Dose Level 1; Drug: Cisplatin - Dose Level 2; Radiation: Dose Level 1; Radiation: Dose Level 2 Sponsor: Nebraska Methodist Health System Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Oropharyngeal Cancer | Research | Skin Cancer | Squamous Cell Carcinoma